Skip to main content
. Author manuscript; available in PMC: 2009 Jun 2.
Published in final edited form as: Mov Disord. 2008 Apr 15;23(5):700–707. doi: 10.1002/mds.21897

TABLE 2.

Odds ratios for placebo-associated improvement in dyskinesia, showing influences of shifts in the three prognostic baseline factors

Age (yr) Baseline UPDRS motor
score
Baseline daily L-dopa
(mg)
Probability Odds Odds ratio relative
to first row
66 22.4 780 0.37 0.59 1.00
66 + 10 22.4 780 0.42 0.72 1.24
66 − 10 22.4 780 0.32 0.47 0.81
66 22.4 + 10 pts 780 0.32 0.47 0.80
66 22.4 − 10 pts 780 0.42 0.72 1.25
66 22.4 780 + 300 0.33 0.52 0.86
66 22.4 780 − 300 0.40 0.69 1.17
66 + 10 22.4 − 10 pts 780 − 300 0.51 1.07 1.80
66 − 10 22.4 + 10 pts 780 + 300 0.25 0.33 0.55

Bold markings highlight the influence of shifting the identified factor upwards or downwards, and the final two rows show the probability of showing placebo-associated improvement with all three factors shifted in the direction of maximally enhancing (second from the bottom row) or maximally diminishing (the bottom row) placebo response. Probability (P) of obtaining the response and the odds of obtaining the response (P/1 – P) are mathematically related, but shown separately.